Núria Amigó Grau received her PhD in Physics and Biomedical Engineering from Rovira i Virgili University, and is now an Associate Professor in Biostatistics at the same institution. She worked as a researcher at Brigham and Women’s Hospital/Harvard Medical School during her PhD. In 2013, she co-founded Biosfer Teslab and was promoted to Managing and Scientific Director in subsequent years. In 2021, she joined the Lipoprotein and Vascular Disease Commission of the Sociedad Española de Medicina de Laboratorio, and since 2022, she has been an elected member of the European Lipoprotein Club Organizing Committee. Her research topics mainly include: cardiovascular diagnostics, lipidomics, biomarker discovery, and machine learning applications in biomedical research. She has received several distinctions, including the Young Academic Talent Award from the Catalan Foundation Gresol (2016) and The Innovation Prize from the Elzaburu Foundation (2019).
Núria Amigó Grau received her PhD in Physics and Biomedical Engineering from Rovira i Virgili University, and is now an Associate Professor in Biostatistics at the same institution. She worked as a researcher at Brigham and Women’s Hospital/Harvard Medical School during her PhD. In 2013, she co-founded Biosfer Teslab and was promoted to Managing and Scientific Director in subsequent years. In 2021, she joined the Lipoprotein and Vascular Disease Commission of the Sociedad Española de Medicina de Laboratorio, and since 2022, she has been an elected member of the European Lipoprotein Club Organizing Committee. Her research topics mainly include: cardiovascular diagnostics, lipidomics, biomarker discovery, and machine learning applications in biomedical research. She has received several distinctions, including the Young Academic Talent Award from the Catalan Foundation Gresol (2016) and The Innovation Prize from the Elzaburu Foundation (2019).